Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Accounts Payables (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of Accounts Payables data on record, last reported at $4.3 million in Q3 2021.

  • For Q3 2021, Accounts Payables rose 580.59% year-over-year to $4.3 million; the TTM value through Sep 2021 reached $4.3 million, up 580.59%, while the annual FY2020 figure was $732000.0, 77.0% down from the prior year.
  • Accounts Payables reached $4.3 million in Q3 2021 per COGT's latest filing, up from $2.0 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $5.5 million in Q3 2018 and bottomed at $315000.0 in Q1 2021.
  • Average Accounts Payables over 4 years is $2.0 million, with a median of $1.7 million recorded in 2019.
  • Peak YoY movement for Accounts Payables: crashed 77.0% in 2020, then soared 580.59% in 2021.
  • A 4-year view of Accounts Payables shows it stood at $1.5 million in 2018, then skyrocketed by 109.55% to $3.2 million in 2019, then plummeted by 77.0% to $732000.0 in 2020, then soared by 494.13% to $4.3 million in 2021.
  • Per Business Quant database, its latest 3 readings for Accounts Payables were $4.3 million in Q3 2021, $2.0 million in Q2 2021, and $315000.0 in Q1 2021.